Nannapat Sangfuang
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
High-throughput identification of bacterial β-glucuronidase inhibitors using machine learning.
Journal: Gut microbes
Published: June 06, 2026
Unexpected effects of antibiotics on microbiota-mediated drug metabolism in a fistulated dog model.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: September 18, 2025
Assessing the effects of tofacitinib on the gut microbiome in inflammatory bowel disease.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: August 03, 2025
Investigating the bidirectional interactions between senotherapeutic agents and human gut microbiota.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: November 26, 2024
Characterising and preventing the gut microbiota's inactivation of trifluridine, a colorectal cancer drug.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: June 17, 2024
Effects of senotherapeutics on gut microbiome dysbiosis and intestinal inflammation in Crohn's disease: A pilot study.
Journal: Translational research : the journal of laboratory and clinical medicine
Published: May 30, 2024
The colon targeting efficacies of mesalazine medications and their impacts on the gut microbiome.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: January 21, 2024
Advancing oral delivery of biologics: Machine learning predicts peptide stability in the gastrointestinal tract.
Journal: International journal of pharmaceutics
Published: December 05, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026